|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vinyl cyclohexene dioxide |
CAS 106-87-6 | ||
C8H12O2 |
RTECS RN8640000 | ||
|
Synonyms & Trade Names 1-Epoxyethyl-3,4-epoxy-cyclohexane; 4-Vinylcyclohexene diepoxide; 4-Vinyl-1-cyclohexene dioxide |
DOT ID & Guide |
||
Exposure
|
NIOSH REL: Ca TWA 10 ppm (60 mg/m3) [skin] See Appendix A | ||
| OSHA PEL†: none | |||
| IDLH Ca [N.D.] See: IDLH INDEX | Conversion 1 ppm = 5.73 mg/m3 | ||
|
Physical Description Colorless liquid. |
|||
|
MW: 140.2 |
BP: 441°F |
FRZ: -164°F |
Sol: High |
|
VP: 0.1 mmHg |
IP: ? |
|
Sp.Gr: 1.10 |
|
Fl.P(oc): 230°F |
UEL: ? |
LEL: ? |
|
| Class IIIB Combustible Liquid: Fl.P. at or above 200°F. | |||
|
Incompatibilities & Reactivities Alcohols, amines, water [Note: Slowly hydrolyzes in water.] |
|||
|
Measurement Methods OSHA PV2083 See: NMAM or OSHA Methods |
|
Personal Protection & Sanitation (See protection) Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: No recommendation Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Water wash immediately Breathing: Respiratory support Swallow: Medical attention immediately |
|
Important additional information about respirator selection Respirator Recommendations NIOSH At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode (APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister/Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms In animals: irritation eyes, skin, respiratory system; testicular atrophy; leukopenia (reduced blood leukocytes), necrosis thymus; skin sensitization; [potential occupational carcinogen] | |
|
Target Organs
Eyes, skin, respiratory system, blood, thymus, reproductive system Cancer Site [in animals: skin tumors] |
|
| See also: INTRODUCTION See ICSC CARD: 0820 |